All In Biotech

Investigational drug · Phase 3

Active Comparator vaccine

Not approved by FDA. In 6 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Epidemic Meningitis, Meningococcal Vaccines, Herpes Zoster.

Phase 3

Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

6

6 still active

All registered trials

151

Any phase or sponsor naming "Active Comparator vaccine"

First trial start

2026

Jan 10, 2026

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Active Comparator vaccine", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Epidemic Meningitis
  • Meningococcal Vaccines
  • Herpes Zoster

Approved drugs for the same conditions: Herpes and shingles · Infectious disease and vaccines

Largest trials

Live from ClinicalTrials.gov: studies naming "Active Comparator vaccine" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 3 on PubMed

Also in development for Epidemic Meningitis

  • experimental vaccinePhase 34 trials

    Sinovac Biotech Co., Ltd · Epidemic Meningitis, Meningococcal Vaccines

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.